drugset / Trial / NCT02264301

Qingkailing Injection Versus Puerarin Injection on Withdrawal Rate of Corticosteroids in Patients With Active Rheumatoid Arthritis

NCT02264301

Unknown 150 enrolled Chengdu PLA General Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the effect of Qingkailing injection versus Puerarin injection on withdrawal rate of corticosteroids in patients with active rheumatoid arthritis.

Timeline

Start
2014-08
Primary completion
2017-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Puerarin Small molecule 400 mg
Subject Qingkailing Unknown 40 ml

Indications